Together, our findings suggest that modulation of the LFA-1/ICAM-1 molecular pair on ILC2s may represent a promising and unappreciated novel therapeutic strategy regulating trafficking and cytokine production in the context of ILC2-dependent asthma. This evidence concerns the gene ITGAL and asthma.